IL6 and cancer: Together, these data suggest that cancer leads to increased plasma levels of selected pro-inflammatory cytokines, and that increased plasma IL-6 levels, likely resulting from chemotherapy or radiotherapy, may be a key systemic factor involved in, and/or predictive of, cognitive dysfunction (Table 2).